Security key
25253X207
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)
CUSIP: 25253X207
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Voting Common Shares, no par value
- Total 13F shares
- 12,053,996
- Total 13F value
- $95,986,433
- Share change
- -796,042
- Put/Call ratio
- 85%
- SEC-reported price per share
- $7.96
- Number of holders
- 92
- Value change
- -$5,768,433
- Number of buys
- 54
- Number of sells
- 26
- Shares outstanding
- 52,272,727
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
92
Top holders
10
DMAC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
DiaMedica Therapeutics Inc. SEC filings
DiaMedica Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 25253X207
Recent filing periods:
Ownership snapshot
Top reported holders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TRILL AB
Disclosed value leader
Jan Stahlberg
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
3/4/5
13F
Lead comparable stake: 17%
13D/G row: TRILL AB
Showing 1-6 of 15 holder rows.
Quick read
TRILL AB leads the comparable SEC ownership view at 17%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TRILL AB's linked filing trail.
Comparable ownership
Top 5
TRILL AB
17%
TomEnterprise AB
16%
Richard Jacinto II
9.6%
Leon G. Cooperman
6.6%
Jan Stahlberg
17%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TRILL AB |
13D/G
|
17%
|
$70,252,906
8,825,742 shares
|
+$8,447,765 | 31 Dec 2025 |
| TomEnterprise AB |
13D/G
|
16%
|
$32,695,950
8,383,577 shares
|
$0 | 23 Jul 2025 |
| Richard Jacinto II |
13D/G
3/4/5
10%+ Owner
|
9.6%
|
$34,067,114
4,958,823 shares
|
$0 | 30 Sep 2025 |
| Leon G. Cooperman |
13D/G
13F
Cooperman Leon G. · Individual
|
6.6%
|
$28,462,500
3,450,000 shares
|
+$1,486,972 | 31 Dec 2025 |
| Jan Stahlberg |
3/4/5
10%+ Owner
|
17%
|
$75,679,855
8,825,742 shares
|
+$13,589,576 | 17 Nov 2025 |
| Thomas von Koch |
3/4/5
10%+ Owner
|
16%
|
$29,342,519
8,383,577 shares
|
— | 23 Jul 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
92
Shares
12,053,996
Rows available
92
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
77
Q4 2025 holders
92
Holder diff
15
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend